Inclusion of the risk score in decision making of valvular heart disease

Ricardo Casalino1, Max Grinberg

  • 1Instituto do Coração, São Paulo, SP, - Brasil. ricardocasalino@cardiol.br

Insights

Clinical data and risk scores aid decisions for valvular heart disease patients. However, current risk scores like EuroSCORE, STS, and Ambler lack validation in our specific population for predicting mortality.

Area of Science:

  • Cardiology
  • Medical Statistics

Background:

  • Valvular heart disease management relies on clinical data and survival interpretations.
  • Decision-making for interventions requires understanding patient quality of life and prognosis.
  • Interdisciplinary expertise is crucial for optimizing outcomes in valvular heart disease treatment.

Purpose of the Study:

  • To evaluate the utility of risk scores in predicting postoperative mortality for valvular heart disease patients.
  • To assess the applicability of existing risk stratification tools in a specific patient population.

Main Methods:

  • Utilized clinical facts and numerical data for quality of life and survival analysis.
  • Examined the role of validated risk scores incorporating multiple markers.
  • Assessed the predictive accuracy of established tools such as EuroSCORE, STS score, and Ambler Score.

Main Results:

  • Risk scores offer quantitative accuracy to clinical assessments, aiding in objective patient evaluation.
  • Existing risk stratification tools provide valuable data for predicting postoperative mortality.
  • None of the commonly used risk scores (EuroSCORE, STS, Ambler) have been validated within the study's population.

Conclusions:

  • Risk scores are valuable, user-friendly tools for assessing patient risk in valvular heart disease.
  • The lack of local validation for existing risk scores highlights a gap in current clinical practice.
  • Further research is needed to validate or develop appropriate risk stratification tools for this population.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...